Document is current

Alpha-Galactosylceramide/CD1d-Antibody Fusion Proteins Redirect Invariant Natural Killer T Cell Immunity to Solid Tumors and Promote Prolonged Therapeutic Responses

Crossref DOI link: https://doi.org/10.3389/fimmu.2017.01417

Published Online: 2017-11-01

Update policy: https://doi.org/10.3389/crossmark-policy